What is the Neurocrine Biosciences Inc (NBIX) price today?

The price of Neurocrine Biosciences Inc (NBIX) today is $153. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/NBIX

Us company

Neurocrine Biosciences Inc (NBIX) Stock Price Today

Technicals Fundamentals Financials News Corp Action About Compare

24H

YTD

Aura AI Summary

Neurocrine Biosciences (NBIX) trades at $156.49, down 3.37% amid recent safety concerns over Vykat XR. The stock shows strong fundamentals with a P/E of 22.88, net income margin of 20.91%, and robust revenue growth. Technical indicators are bearish, with price near support at $155. Recent Q2 2026 earnings beat estimates, but Q3 expectations are high at $2.59 EPS.

Outlook remains positive due to strong analyst consensus (86.49% buy) and a $208.82 price target, though risks include drug safety issues and competitive pressures. Earnings growth and pipeline advancements offer upside, but volatility from news flow requires careful monitoring.

Read full analysis

Key Stats

Market Cap
$15.33B
Volume
-
Sector
Health
52W High
$185.50
52W Low
$123.10
Typical Hold Time
-
Enterprise Value
$15.34B
Div Yield
-
Trading Activity
-

$153

52W Low: $123.1

12 Feb 2026

52W High: $185.5

30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Most Recent News

Content is generated by Aura AI

Definitive Healthcare posts a stellar 41.44% ROIC, far surpassing its 5.78% capital cost.

Definitive Healthcare Corp. stands out with a remarkable Return on Invested Capital (ROIC) of 41.44%, significantly exceeding its Weighted Average Cost of Capital (WACC) of 5.78%. This means the company generates over seven times the value for every ...

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...

Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...

Catch up fast with Aura AI

Get an AI-generated news summary for this asset in seconds.

Frequently Asked Questions

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

Are US Stocks safe?

Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

Market Cap
$15.33B
Volume
-
Sector
Health
52W High
$185.50
52W Low
$123.10
Typical Hold Time
-
Enterprise Value
$15.34B
Div Yield
-
Trading Activity
-

$153

52W Low: $123.1

12 Feb 2026

52W High: $185.5

30 Jul 2026

Let’s invest in this asset by signing up or download!

Neurocrine Biosciences Inc (NBIX) Stock Price Today

Aura AI Summary

Key Stats

About Neurocrine Biosciences Inc

Most Recent News

Definitive Healthcare posts a stellar 41.44% ROIC, far surpassing its 5.78% capital cost.

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

People also bought

Frequently Asked Questions

Key Stats

Invest

Features

Fees

Learn

Tools

Support

iOS App Store

Google Play Store